Articles tagged with Recreational Drugs
Researchers suggest separate weight-driven tables for different types of defendants, eliminating disparities in crack and methamphetamine sentences. The study proposes alternative approaches to define relative sentences for psychostimulants and opioids based on harms associated with each type of drug.
A 15-year retrospective study found that physical assault and excessive MDMA use are primary causes of nightclub deaths in the UK. The study reveals a significant number of young women are at higher risk of dying from drug-related causes.
Researchers detected seven of nine nitazene compounds in wastewater from a treatment plant serving nearly 300,000 people, with metonitazene found at similar levels before and after major events. Early detection is crucial for addressing the overdose crisis and preventing further loss of life.
A new study by Carnegie Mellon University researchers found that opioid consumption intensity varies enormously across different populations and contexts. The study suggests that tracking average intensities of use could improve our understanding of consumption patterns and inform drug policy and treatment strategies.
A longitudinal cohort study found that recreational cannabis legalization was associated with increased cannabis and electronic nicotine delivery systems use, but not a significant increase in cigarette use. The study suggests that commercialization policy should be closely monitored as retail cannabis expands.
A recent study by Carnegie Mellon University found that illegally manufactured fentanyl primarily enters the US via counties along the Canadian border. The analysis revealed these counties accounted for over 40% of large fentanyl seizures in 2023-2024, despite comprising only 3.1% of the national population. This finding undermines eff...
A recent US study found that nearly one in five adults have used multiple drugs in the past year, revealing new patterns in substance use. The study identified four distinct patterns of drug use among prescription, recreational, and illegal users, highlighting the need for tailored prevention and treatment strategies.
A new study published in the Journal of Studies on Alcohol and Drugs suggests that mandatory warning signs at cannabis dispensaries may not be effective in deterring pregnant users. In fact, many participants reported distrust towards the content of the warnings, viewing them as stigmatizing or negative. The researchers interviewed 34 ...
A new study at Columbia University Mailman School of Public Health found no changes in opioid outcomes among the general population with the states' passage of medical and recreational marijuana laws. Decreases in opioid outcomes were observed among people reporting cannabis use but not when both medical and recreational use laws existed.
A study analyzed police data in Atlantic City, NJ before and after the start of the pandemic, finding a temporary reduction in dispatched calls for mental health services. Police-initiated contact also decreased slightly after restrictions began, but no long-term trend was found.
A new study found that individuals with hallucinogen-related emergency department visits are at a high risk of developing schizophrenia. The study analyzed health data for over 9.2 million individuals in Ontario, Canada, and found a 21-fold increased risk of schizophrenia compared to the general population.
A recent study found that synthetic opioid drug overdoses are becoming increasingly common in Australia, particularly due to the presence of fentanyl. The researchers highlighted the need for safe consumption spaces and increased awareness about the risks of fentanyl contamination.
A national cohort study found that no routine clinical lab test can aid in diagnosing post-acute sequelae of SARS-CoV-2 infection. Ongoing inflammation is thought to contribute to symptoms like anosmia and PASC. Researchers also discovered a link between SARS-CoV-2 and diabetes risk, independent of PASC symptoms.
A new study reveals that coca plants grown for cocaine production are difficult to distinguish from wild-growing varieties based on leaf shape and size. The researchers used genetic analysis to estimate when different coca species and varieties originated, suggesting a longer evolutionary history than previously thought.
A new qualitative research project explores young adults' (18-30) leisure motivations for using cannabis, revealing a shift towards viewing it as a recreational activity. Participants describe cannabis as offering a leisure state of mind and a way to enhance socialization and pleasurable experiences.
A new study published in Clinical Chemistry and Laboratory Medicine reveals that smartphone swabs can successfully detect drugs on phone surfaces. The method, which uses dry swabs, identified MDMA, cocaine, and THC as the most common substances, with other drugs including ketamine, LSD, and heroin also detected.
Researchers found that medical cannabis legislation in the US improves mental health for individuals with chronic pain and those using marijuana for medical reasons. However, no negative impact was observed on recreational users or younger populations.
Between 2017 and 2022, US law enforcement seizures of psilocybin mushrooms increased dramatically, with the total weight seized peaking in 2021. This trend reflects growing interest in psychedelic use, despite limited self-reported data on prevalence.
Seizures of psilocybin, a hallucinogenic compound found in psychedelic mushrooms, have surged by 369% across the US since 2017, according to a new study. The highest number of seizures were recorded in the Midwest and West regions, with nearly quadrupled amounts of seized drugs.
A new peer-reviewed study suggests that cannabis is having no significant effect on people's use of opioids, taken outside of medical guidance. The findings have substantial implications for U.S. treatment programs, which still require patients to abstain from cannabis before qualifying for potentially life-saving treatment.
A new U-M study found that 72% of adults in the US have heard of CBD, while fewer are aware of other hemp-derived cannabinoids like delta-8-THC and CBG. The products' lack of regulation and inadequate safety testing pose health risks to consumers, especially young people.
A new study published in Cell Reports mapped ketamine's effects on the brains of mice, revealing widespread structural changes in the dopamine system after repeated use. The findings suggest that targeting specific areas of the brain with ketamine therapy could minimize unintended effects.
Researchers developed a more efficient way to find emerging designer drugs in urine samples, uncovering new synthetic opioids, benzodiazepines, and stimulants that evaded initial screening. The approach can support public health and safety by enabling swift identification of new substances.
Researchers found that MDMA increased feelings of connection and oxytocin levels in volunteers, while methamphetamine also showed similar effects. These findings suggest potential therapeutic benefits for traditional talk therapy.
A French study found that recreational drug use was associated with a nearly 9-fold higher rate of death or need for emergency intervention in cardiac intensive care patients. The study detected various substances in 1 in 10 patients, with cannabis being the most frequently detected substance.
An Oregon State University study found that young adults not in college became more frequent users of cannabis and met criteria for cannabis use disorder after state legalization. The prevalence of frequent cannabis use increased by 5 percentage points among non-college young adults, while college students saw a smaller increase.
Young adults' past-year use of non-LSD hallucinogens increased from 3.4% in 2018 to 6.6% in 2021, raising public health concerns. The study found that male and white young adults used these substances more frequently.
A large UK case series reveals a predominance of young Asian men among those with nitrous oxide-induced myeloneuropathy, suggesting genetic or social factors. The study found that these patients often experienced severe symptoms such as pins and needles, bladder difficulties, and poor balance.
A significant increase in illicit ketamine seizures in the US has raised concerns about the risks of non-medical and recreational use, as well as the presence of fentanyl. The study found a 349% rise in seizures from 2017 to 2022, with the highest numbers reported in Tennessee, Florida, and California.
Research found that occasional cannabis use during early pregnancy can significantly reduce birth weight, even if continued use is not observed. Continued exposure results in largest deficiencies, with newborns exposed to marijuana throughout gestation being nearly 200g lighter and having smaller head circumferences.
A Columbia University study found that casual cannabis use by adolescents raises the risk of depression, suicidality, and problem behaviors. Nondisordered cannabis users were 2-2.5 times more likely to have adverse mental health outcomes and behavioral problems compared to teens who didn’t use cannabis.
A study in Auckland, New Zealand has detected methamphetamine and other substances in the air for the first time in Oceania. The largest concentration of methamphetamine was found to be 104 picograms per cubic meter, highlighting the need for better air quality monitoring.
Researchers found that clinicians ordered more frequent newborn drug tests for Black newborns after recreational cannabis legalization, highlighting concerns about structural racism and disproportionate testing. The study calls for further exploration of how institutional racism affects healthcare outcomes for Black families.
A recent study published in Academic Emergency Medicine found that combining cocaine with ethanol increases the risk of cardiac arrest, higher lactate concentrations, and lower occurrence of myocardial injury. The study suggests that cocaethylene, a metabolite of cocaine and ethanol, is more toxic than either substance alone.
The study calls for easier access to naloxone, including over-the-counter distribution, to address the US opioid epidemic. With millions lacking access, health providers are urged to include naloxone in treatment programs and counsel patients' families on its use.
A new study by UCL and King's College London researchers found that vaporized cannabis has the same short-term effects on adolescents (16-17 years old) as on adults (26-29 years old), regardless of CBD levels. The study also showed that CBD does not reduce the psychoactive effects of THC in cannabis.
A study published in the Journal of the American Geriatrics Society found a sharp increase in cannabis-related emergency department visits among California adults ages 65 and older from 2005 to 2019. The rate increased by 1,808%, with more than 12,000 visits reported in 2019.
A national US study found a 245% increase in child marijuana abuse and a decline in alcohol abuse over the past 20 years. The study tracked intentional misuse and abuse reported to the National Poison Data System from 2000 to 2020, revealing over 338,000 instances of child abuse or misuse.
A new national study found pregnant women in legalized US states are far more likely to use cannabis, with a 4.6 times higher rate compared to CBD-only states. The study emphasizes the need for prenatal and primary care providers to screen and counsel patients regarding cannabis use in pregnancy.
A new study urges regulators to take a closer look at the health and safety risks of the growing medicinal and recreational cannabis market. The research team found that many pesticides in cannabis cultivation were highly unlikely to be used, but still detected, highlighting the need for stricter regulations.
A new study published in the journal Addiction found that recreational cannabis legalization in US states led to a 20% increase in cannabis use frequency, particularly among identical twin pairs. The study analyzed data from over 1,400 individuals and suggested that recreational legalization caused an increase in cannabis use.
A systematic review of 20 studies involving almost 120,000 people found that high-potency cannabis use is associated with a higher risk of addiction and mental health problems, including psychotic disorders. The study suggests that reducing the potency of cannabis products could help minimize these harms.
Research found a 5.8% increase in traffic crash injuries and a 4.1% increase in fatal crash rates after legalization. States with retail sales saw an initial jump in injury crash rate before it decreased.
A study found that cannabis use and daily use are more common in US states with recreational cannabis laws compared to those without. Cigarette smokers in these states have even higher rates of cannabis use.
A new study led by UCL and King's College London researchers found that adolescents are three times more likely to develop a cannabis addiction than adults. However, they do not appear to be at increased risk of subclinical depression or anxiety. In contrast, adult users who become addicted may experience worsening mental health symptoms.
Research finds that cannabis users have a significantly higher risk of emergency room visits and hospital admissions for any cause. However, the study did not find a significant link between cannabis use and respiratory health issues. The authors conclude that further research is needed to confirm their findings.
Researchers found that young people aged 12-20 were more likely to become cannabis users in states with legalized recreational use compared to those without. The study also documented an increased likelihood of cannabis use among adults in these states.
A new study of over 20,000 Americans found that state legalization of recreational cannabis leads to increased cannabis use, especially among young people. The study suggests that this could have detrimental health effects, including impaired respiratory function and cardiovascular disease.
A study by Cornell researchers found that recreational marijuana access significantly decreases prescriptions for pain, depression, anxiety, sleep, psychosis, and seizures in state Medicaid programs. This reduction could lead to significant cost savings for state Medicaid programs.
Adults who have used psilocybin are 30% less likely to develop opioid use disorder, according to a nationally representative survey. Psilocybin use is also associated with reduced symptoms of opioid dependence and abuse.
Researchers from UBC Okanagan and the University of Exeter found ketamine to have significant anti-depressant and anti-suicidal effects in a comprehensive systematic review. The study suggests ketamine may be helpful in treating various disorders, including eating disorders, substance use, and anxiety.
A new study by University of Chicago researchers found no evidence that LSD microdosing improves mood and cognitive function. However, the study did confirm that taking small doses of LSD is safe, with participants building a tolerance to the drug over time.
A new study found a 1,886% increase in opioid-related overdose deaths among U.S. adults aged 55 and older between 1999 and 2019. Contributing factors include ageism, social isolation, depression, and declining cognitive function.
Research identifies maladaptive nature of drug-seeking habits as key factor in perpetuating addiction and relapse. Drug-paired cues can activate flexible goal-directed behaviors, driven by negative emotional urgency.
A new study detected designer drugs like bath salts and eutylone in wastewater samples from 10 countries over the New Year. The study found that New Zealand consumed the highest loads of NPS, with high levels of eutylone also detected in Australia and Canada.
US car crash deaths involving cannabis have doubled between 2000 and 2018, with those also involving alcohol increasing by over 100%. Researchers found a significant link between cannabis use and increased risk of alcohol involvement in fatal crashes.
A new study finds that recreational ketamine use has increased in recent years, coinciding with its FDA approval for depression treatment. Despite this rise, the drug remains relatively rare, affecting less than 1% of U.S. teens and adults.
A new study reveals that THC can cause birth defects in genetically predisposed mice, highlighting the risks of cannabis consumption during pregnancy. Pups with a mutation in Hedgehog signalling developed brain and face defects, emphasizing the need for further research into human health implications.
Researchers found that dancing and psychedelic drugs are associated with feelings of awe and social bonding in rave attendees. This study suggests that these experiences can be beneficial for therapeutic settings, potentially reducing stigma around psychedelic use.
A wastewater study conducted in Australia during the 2020 COVID-19 lockdown found that cannabis use surged, while methamphetamine (ice) use plummeted. The research, led by the University of South Australia, analyzed wastewater samples from 20 treatment plants across the country and showed a significant increase in cannabis use nationwide.